Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime/MM-GBSA calculation

Developing chemicals that inhibit checkpoint kinase 1 (Chk1) is a promising adjuvant therapeutic to improve the efficacy and selectivity of DNA‐targeting agents. Reliable prediction of binding‐free energy and binding affinity of Chk1 inhibitors can provide a guide for rational drug design. In this s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of computational chemistry 2011-10, Vol.32 (13), p.2800-2809
Hauptverfasser: Du, Juan, Sun, Huijun, Xi, Lili, Li, Jiazhong, Yang, Ying, Liu, Huanxiang, Yao, Xiaojun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Developing chemicals that inhibit checkpoint kinase 1 (Chk1) is a promising adjuvant therapeutic to improve the efficacy and selectivity of DNA‐targeting agents. Reliable prediction of binding‐free energy and binding affinity of Chk1 inhibitors can provide a guide for rational drug design. In this study, multiple docking strategies and Prime/Molecular Mechanics Generalized Born Surface Area (Prime/MM‐GBSA) calculation were applied to predict the binding mode and free energy for a series of benzoisoquinolinones as Chk1 inhibitors. Reliable docking results were obtained using induced‐fit docking and quantum mechanics/molecular mechanics (QM/MM) docking, which showed superior performance on both ligand binding pose and docking score accuracy to the rigid‐receptor docking. Then, the Prime/MM–GBSA method based on the docking complex was used to predict the binding‐free energy. The combined use of QM/MM docking and Prime/MM–GBSA method could give a high correlation between the predicted binding‐free energy and experimentally determined pIC50. The molecular docking combined with Prime/MM–GBSA simulation can not only be used to rapidly and accurately predict the binding‐free energy of novel Chk1 inhibitors but also provide a novel strategy for lead discovery and optimization targeting Chk1. © 2011 Wiley Periodicals, Inc. J Comput Chem, 2011
ISSN:0192-8651
1096-987X
DOI:10.1002/jcc.21859